Business Wire

CA-CONFLUENT,-INC.

Share
Confluent Announces Stream Governance, the Industry’s First Governance Suite for Data in Motion

Confluent, Inc. (NASDAQ: CFLT), the platform to set data in motion, today unveiled the industry’s first governance suite for streaming data. Offered as a fully managed cloud solution, Stream Governance delivers a simple, self-service experience to discover, understand, and trust the real-time data that flows throughout modern businesses. Distributed teams now have quick, easy access to the data that’s critical to developing more real-time applications and business operations, all while maintaining data security and privacy. This provides organizations with a safe way to expand the use of data in motion and create a central nervous system that ties together disparate applications and systems. With streaming data available to more people, teams can unlock entirely new use cases that drive differentiation and exceed customer demands.

“With the sharp rise of real-time data, the need for governance over data in motion is more critical than ever,” said Stewart Bond, Research Director, Data Integration and Data Intelligence Software, IDC. “Confluent’s Stream Governance suite allows customers to harvest intelligence about, and gain control of, data in motion, to enable a balance between innovation and trust while expanding the power of streaming data in every part of the business.”

The ability to establish and operate around a central nervous system will be a major factor in determining who wins in the next stage of digital disruption. However, as the number of data sources continues to rise, it’s more challenging than ever to fully understand and safely manage all the data streaming across a business. Too often, this knowledge is in the hands of just a few streaming experts, creating unknown risks and blocking many teams from building applications powered by data in motion. To keep pace with evolving business needs and customer demands, organizations must be able to safely share data knowledge across more streams, more teams, and more use cases.

"Data in motion is becoming the key platform for companies looking to unlock their data,” said Jay Kreps, Co-founder and CEO, Confluent. “But to truly unlock data, it isn't enough to make it accessible. You need to also ensure it is correct, compliant, and discoverable. With Stream Governance, we make the governance of streaming data easy and integrated so customers can ensure that their data is a solid foundation for their next generation digital initiatives.”

Introducing Stream Governance

Stream Governance makes the value of real-time data available across an organization, with both self-service data discoverability and scalable controls for long-term data compatibility and compliance. This new suite of capabilities establishes trust in the real-time data moving throughout your business while delivering an easy, cloud-native experience that empowers teams across any organization to quickly put these event streams to work.

"To provide homes where people feel safe and secure, we need our data in the exact same state," said Mustapha Benosmane, Digital Product Leader, Adeo. "While Confluent ensures that our complex and ever-evolving data streams are always fit for use, keeping the technology framed and easy to use for our teams is one of our priorities. With Stream Governance, we have an additional tool to help developers in our growing engineering organization keep improving the way we work with data in motion. They'll have easier ways to not only find the data they need but to truly understand it and gain the confidence required to put it to use right away."

Share the power of data in motion with these new cloud capabilities that are now available as part Stream Governance:

Stream catalog: Increase collaboration and productivity with self-service data discovery

"When responsible for the safety of our customers and their families, confidence in data is of the highest priority,” said Sean Schade, Distinguished Architect, Care.com. “With tools like Schema Registry, we have access to a trusted, scalable supply of real-time data streams across cloud environments to power the services today’s families need. And we’re excited about the launch of Confluent’s stream catalog which can allow us to develop classifications of sensitive data and an easier means of maintaining regulatory compliance.”

With billions of events streaming across a business daily, locating the data needed to build and improve applications becomes a daunting, time-consuming task. Stream catalog allows individuals across teams to collaborate within a centralized, organized library designed for sharing, finding, and understanding the high-quality data needed to drive their projects forward quickly and efficiently. This includes topics, schemas, fields in schemas, clusters, connectors, and more. It’s like a digital library for data in motion, allowing any user—experienced with streaming data or not—to put it to use right away.

Stream lineage: Understand complex data relationships and uncover more insights

“As the world's leading global equipment marketplace, we make buying and selling easy with critical customer services like real-time online bidding powered by data in motion,” said Nic Pegg, Platform Lead, Ritchie Bros. “Confluent’s Stream Governance suite will play a major role in our expanded use of data in motion and creation of a central nervous system for the enterprise. With the self-service capabilities in stream catalog and stream lineage, we’ll be able to greatly simplify and accelerate the onboarding of new teams working with our most valuable data.”

To make updates to mission-critical applications or answer questions on important subjects like data regulation and compliance, teams need an easy way to comprehend how data is moving between different systems and applications within a business. Stream lineage provides an end-to-end map of event streams with both a bird’s-eye view and drill-down magnification. With a better understanding of where data originated, where it’s going, and how it’s transformed, developers can move projects forward with assurance their work won’t cause negative or unexpected downstream impact. This also helps accelerate the movement of data in motion workflows from on-premises to the cloud.

Stream quality: Deliver trusted, high-quality event streams to the business

"Running a modern bank serving fast growing enterprises requires data in motion we can trust," said Andreas Piefke, Head of Cloud Architecture, Judo Bank. "Schema Registry allows us to provide customers with reliable, real-time experiences for tasks like loan processing while we maintain focus on furthering innovations. We're excited about new discovery capabilities within Stream Governance which will enable us to expand data in motion across teams and operate like a truly event-centric business.”

Being able to control the quality of data being written to a streaming ecosystem is critical to protecting against system failures and corruption. Confluent’s Schema Registry helps organizations scale data integrity without adding operational complexity. As part of this launch, Confluent is announcing the new Schema Management UI , which makes it easier than ever to understand which schemas exist, how they are defined, and where they are used. Standardizing around well-defined and agreed upon schema structures allows teams to develop resilient data in motion pipelines prepared for safe, compatible evolution over time.

Dive deeper into Stream Governance at Kafka Summit Americas

Learn more about today’s announcement at Kafka Summit Americas . Confluent Co-founder and CEO Jay Kreps will introduce Stream Governance during his keynote “Data Mess to Data Mesh ” at 9:00 a.m. PT today. Also catch “Navigating Your Data in Motion ” at 11 a.m. PT for a walkthrough and demo. Register here.

Additional resources

About Confluent

Confluent is pioneering a fundamentally new category of data infrastructure focused on data in motion. Confluent’s cloud-native offering is the foundational platform for data in motion—designed to be the intelligent connective tissue enabling real-time data, from multiple sources, to constantly stream across the organization. With Confluent, organizations can meet the new business imperative of delivering rich, digital front-end customer experiences and transitioning to sophisticated, real-time, software-driven backend operations. To learn more, please visit www.confluent.io .

The preceding outlines our general product direction and is not a commitment to deliver any material, code, or functionality. The development, release, timing, and pricing of any features or functionality described may change. Customers should make their purchase decisions based upon services, features, and functions that are currently available.

Confluent and associated marks are trademarks or registered trademarks of Confluent, Inc.

Apache® and Apache Kafka® are either registered trademarks or trademarks of the Apache Software Foundation in the United States and/or other countries. No endorsement by the Apache Software Foundation is implied by the use of these marks. All other trademarks are the property of their respective owners.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye